Valley View Health Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 227 Valley View Dr, Waverly, OH 45690 Phone: 740-947-7726 Fax: 740-947-9354 |
Valley View 23 North Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13800 Us Highway 23, Waverly, OH 45690 Phone: 740-947-2480 |
Pike County Recovery Council Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 217 E Emmitt Ave, Waverly, OH 45690 Phone: 740-947-6727 Fax: 740-947-6917 |
Valley View 23 North Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13800 Us Highway 23, Waverly, OH 45690 Phone: 740-947-2480 |
Valley View Health Center Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 227 Valley View Dr, Waverly, OH 45690 Phone: 740-947-7726 Fax: 740-947-9354 |
News Archive
Failure to deliver complete nursing care explains why hospitals with lower registered nursing staff levels have a higher risk of patient death, a new University of Southampton study has shown.
Preterm born children are more likely to have problems in cognitive functioning and mental health. Then again, most preterm infants grow up to be just as happy, healthy and smart as their peers. Among the preterm infants, who are at risk?
The American Association of Neuroscience Nurses (AANN) and Association for Rehabilitation Nurses (ARN) are proud to announce the newest addition to the respected AANN Clinical Practice Guideline series, Care of the Patient with Mild Traumatic Brain Injury.
New genomic research led by UC San Francisco scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain cancers known as gliomas.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has entered into a securities purchase agreement for a private placement financing with a select group of institutional investors, including New Enterprise Associates and Venrock.
› Verified 8 days ago